Melanoma/Skin Cancer News

Pembrolizumab Plus Low-Dose Ipilimumab Safe in Melanoma, Renal Cell Carcinoma

Major advance in melanoma drug combinations

After melanoma, higher risk of other cancers

Targeted drug shows promise against melanoma: study

Melanoma / Skin Cancer news headlines provided courtesy of Medical News Today.